Vaccine group Gavi seeks to broaden donor base as aid budgets shrink
Gavi is aiming to raise $9 billion at a summit in Brussels later this month for its work from 2026-2030, but countries including the United States, the United Kingdom and France have all signalled that they plan to slash global aid funding in the coming years, and their pledges remain uncertain.
"We want to broaden our donor base," Gavi's Sania Nishtar told Reuters in Rabat, where she met officials to encourage Morocco to join as a new donor.
She said that India and Indonesia, which had previously been supported by Gavi, were now contributing as donors to the organization, which works with low and middle-income countries to buy vaccines for diseases from measles to cholera.
Other countries like Portugal have also increased their funding commitment, she said.
During her Morocco visit, Nishtar toured a vaccine manufacturing facility near Casablanca under development by Marbio, a biopharmaceutical venture backed by Morocco.
She said the plant had "a good chance" of benefiting from Gavi's $1.2 billion African Vaccine Manufacturing Accelerator, a scheme aimed at boosting vaccine production on the continent.
Gavi has already sought out more private sector donors, initiated cost-saving initiatives, and discussed closer collaboration with other global health groups as part of plans to try to tackle potential shortfalls in funding.
Nishtar said the organization was making contingency plans, but she hoped that donors at the June 25 summit would give enough that they would not be needed.
A U.S. government document showed in March that the U.S., which has previously given around $300 million to Gavi annually, did not plan any future funding.
Nishtar said that Gavi has not yet received this year's funding, which has already been approved by Congress.
Gavi is currently focused on combating a global measles outbreak and is responding to cholera outbreaks in Sudan, South Sudan, and Angola, where it has made special arrangements to supply vaccines from its stockpiles, Nishtar said.
It is also supporting Sierra Leone, where the spread of mpox has accelerated.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
an hour ago
- Reuters
Fact Check: Statement from Namibian president rejecting Gates Foundation contraceptives trial is fake
Online claims that the Namibian president released a statement rejecting a proposal by the Gates Foundation to conduct trials of a contraceptive device are false. The claims followed an August 4 announcement, opens new tab by the Gates Foundation committing $2.5 billion to 'accelerate research and development on women's health' by 2030. This includes 'contraceptive innovation' and a focus on low- and middle-income countries, Reuters reported. An August 11 Facebook post, opens new tab attributed an 'official statement' to President Netumbo Nandi-Ndaitwah rejecting a supposed Gates Foundation proposal to conduct trials of a hormonal intrauterine device, designed to prevent pregnancy for up to eight years. 'Any attempt to hinder or suppress the growth of human potential in Namibia constitutes a grave injustice to our people and their future,' read the statement attributed to Nandi-Ndaitwah. TikTok posts, opens new tab made the same claim on August 12. On August 11, the X account linked to the Namibian presidency's official website labelled a screenshot, opens new tab of one of these posts as 'fake.' The presidency did not respond to Reuters' request for comment. The Gates Foundation told Reuters that it is 'not undertaking any H-IUD (hormonal intrauterine device) work in Namibia,' but that it does 'work with partners to expand access to trusted, voluntary options like H-IUDs in other countries.' The foundation added that the quote attributed to the president was 'fabricated,' saying that the presidency has 'dismissed the claims as unfounded,' referring to the post by the presidency's X account. Reuters found no statement rejecting any such trials published on the Namibian presidency's official website or associated social media channels. False. The Namibian president did not publicly reject a proposal by the Gates Foundation to conduct contraceptive trials. No such trial is taking place in Namibia, and the presidency said a statement attributed to Netumbo Nandi-Ndaitwah was fake. This article was produced by the Reuters Fact Check team. Read more about our fact-checking work.
The Independent
10 hours ago
- The Independent
New malaria drug for babies offers hope to health workers in Uganda
Alice Nekesa did not know she was infected with malaria-causing parasites until it was too late. She was in the fourth month of pregnancy last year when she started bleeding, a miscarriage later attributed to untreated malaria in her. The Ugandan farmer said recently that she regretted the loss of what would have been her second child 'because I didn't discover malaria and treat it early.' Variations of such cases are commonly reported by Ugandan health workers who witness stillbirths or feverish babies that die within days from undiagnosed malaria. The deaths are part of a wider death toll tied to the mosquito-borne disease, the deadliest across Africa, but one easily treated in adults who seek timely medical care. Until recently, a major gap in malaria treatment was how to care for newborns and infants infected with malaria who weren't strong enough to receive regular medication. That changed last month when Swiss medical regulators approved medicine from the Basel-based pharmaceutical company Novartis for babies weighing between 2 and 5 kilograms (nearly 4½ to 11 pounds). Swissmedic said the treatment, a sweet-tasting tablet that disperses into a syrup when dropped into water, was approved in coordination with the World Health Organization under a fast-track authorization process to help developing countries access much-needed treatment. Africa's 1.5 billion people accounted for 95% of an estimated 597,000 malaria deaths worldwide in 2023, according to the WHO. More than three-quarters of those deaths were among children. In Uganda, an east African country of 45 million people, there were 12.6 million malaria cases and nearly 16,000 deaths in 2023. Many were children younger than 5 and pregnant women, according to WHO. Nigeria, Congo and Uganda — in that order — are the African countries most burdened by malaria, a parasitic disease transmitted to humans through the bites of infected mosquitoes that thrive and breed in stagnant water. The drug approved by Swiss authorities, known as Coartem Baby in some countries and Riamet Baby in others, is a combination of two antimalarials. It is a lower dose version of a tablet previously approved for other age groups, including for older children. Before Coartem Baby, antimalarial drugs designed for older children were administered to small infants with careful adjustments to avoid overdose or toxicity. Ugandan authorities, who have been working to update clinical guidelines for treating malaria, say the new drug will be rolled out as soon as possible. It is not yet available in public hospitals. The development of Coartem Baby has given hope to many, with local health workers and others saying the medicine will save the lives of many infants. Ronald Serufusa, the top malaria official for the district of Wakiso, which shares a border with the Ugandan capital of Kampala, said he believes Coartem Baby will be available 'very, very soon' and that one priority is sensitizing the people adhering to treatment. Some private pharmacies already have access to Coartem Baby, 'flavored with orange or mango' to make it palatable for infants, he said. During the so-called malaria season, which coincides with rainy periods twice a year, long lines of sick patients grow outside government-run health centers across Uganda. Many are often women with babies strapped to their backs. Health workers now are trained to understand that 'malaria can be implicated among newborns,' even when other dangerous conditions like sepsis are present, Serufusa said. 'If they don't expand their investigations to also suspect malaria, then it goes unnoticed,' he said, speaking of health workers treating babies. The Malaria Consortium, a global nonprofit based in London, in a statement described the approval of Coartem Baby as 'a major leap forward for saving the lives of young children in countries affected by malaria.' In addition to Uganda, the drug will be rolled out in Burkina Faso, Côte d'Ivoire, Kenya, Malawi, Mozambique, Nigeria, and Tanzania, the group said. Jane Nabakooza, a pediatrician with Uganda's malaria control program, said she expects the government will make Coartem Baby available to patients free of charge, even after losing funding when the U.S. shrank its foreign aid program earlier this year. Some malaria funding from outside sources, including the Global Fund to Fight AIDS, Malaria and Tuberculosis, remains available for programs such as indoor spraying to kill mosquitoes that spread the malaria-causing parasite. Because of funding shortages, 'we are focusing on those that are actually prone to severe forms of malaria and malaria deaths, and these are children under 5 years,' she said. ___ The Associated Press receives financial support for global health and development coverage in Africa from the Gates Foundation. The AP is solely responsible for all content. Find AP's standards for working with philanthropies, a list of supporters and funded coverage areas at
The Guardian
21 hours ago
- The Guardian
Diphtheria cases spiralling in Somalia, health officials warn
Diphtheria cases are rapidly increasing across Somalia, officials and humanitarians warn, with children accounting for more than 97% of the cases. Diphtheria, a highly contagious and deadly bacterial disease that mainly affects children, is preventable by a vaccine. While Somalia has improved vaccination rates in recent years, the medical charity Médecins Sans Frontières (MSF) blames the uptick in cases on persisting immunisation gaps. Abdulrazaq Yusuf Ahmed, the director of Demartino public hospital in the capital, Mogadishu, said: 'The number of recorded cases of children sick with diphtheria has increased across the regions in the whole country. We have received about 49 patients in the whole of 2024 but this year, 2025, we have received 497 diphtheria cases during the last four months alone.' Deaths had risen from 13 to 42, according to a report by Ahmed's hospital this month. The report described the resurgence of diphtheria as 'one of the most urgent and dangerous threats to public health'. Earlier this month, the health ministry said it had recorded 1,616 cases and 87 deaths from the disease so far this year. MSF's Somalia medical coordinator, Frida Athanassiadis, said: 'We are seeing a rapid increase in diphtheria among children under 15 in central Somalia,' adding that they accounted for roughly 97% of cases. 'Low vaccination coverage, vaccine hesitancy and poor living conditions are driving the spread.' Athanassiadis said that in some medical centres the basic resources were 'insufficient to cope with rising caseloads'. MSF said while teams initially had a small emergency stock of the antitoxin, it had now been exhausted, with the health ministry and the World Health Organization helping to distribute the 'limited available stock based on needs'. In July, Save the Children warned that since April cases of measles, diphtheria, whooping cough, cholera and severe respiratory infections in Somalia had doubled from roughly 22,600 to more than 46,000. About 60% of the cases were children under five, it said. 'The sharp rise in vaccine-preventable diseases is linked to the recent aid cuts, which have impacted the health system's capacity to deliver essential services, including routine immunisation, and to treat and run catch-up campaigns to increase the immunity necessary to halt the outbreak,' the NGO said. In Mogadishu, one resident, Abdiwahid Ali, said: 'Many children in my neighbourhood are sick, some of them hospitalised.' Anab Hassan, a grocer, said people were concerned about the outbreak. 'A friend of mine lost a five-year-old daughter who was diagnosed with diphtheria, and several others told me their children are sick and coughing,' she said. 'We hear about children getting sick every day.'
